InvestorsObserver
×
News Home

Do Analysts Expect Intercept Pharmaceuticals Inc (ICPT) Stock to Rise?

Friday, August 07, 2020 03:37 PM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Expect Intercept Pharmaceuticals Inc (ICPT) Stock to Rise?

Analysts who follow Intercept Pharmaceuticals Inc (ICPT) on average expect it to add 68.11% over the next twelve months. Those same analysts give the stock an average rating of Buy.

That average rating earns the stock an Analyst Ranking of 29, which means it ranks higher than 29 of stocks, based on data compiled by InvestorsObserver.

Overall Score - 3.7
Wall Street analysts are rating ICPT a Buy today. Find out what this means to you and get the rest of the rankings on ICPT!

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers.

InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With Intercept Pharmaceuticals Inc Stock Today?

Intercept Pharmaceuticals Inc (ICPT) stock is trading at $48.60 as of 3:27 PM on Friday, Aug 7, an increase of $1.42, or 3.01% from the previous closing price of $47.18. The stock has traded between $46.20 and $49.25 so far today. Volume today is low. So far 465,444 shares have traded compared to average volume of 1,306,613 shares.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App